datab = [{},{"Attribute Name":"Contrast/Bolus Agent Sequence","Tag":"(0018,0012)","Type":"1","Attribute Description":"Sequence that identifies one or more contrast agents administered prior to or during the acquisition. One or more Items shall be included in this Sequence."},{"Attribute Name":">Include","Tag":"Baseline ."},{"Attribute Name":">Contrast/Bolus Agent Number","Tag":"(0018,9337)","Type":"1","Attribute Description":"Identifying number, unique within this SOP Instance, of the agent administered. Used to reference this particular agent from the Contrast/Bolus Functional Group Macro. The number shall be 1 for the first Item and increase by 1 for each subsequent Item."},{"Attribute Name":">Contrast/Bolus Administration Route Sequence","Tag":"(0018,0014)","Type":"1","Attribute Description":"Sequence that identifies the route of administration of contrast agent. Only a single Item shall be included in this Sequence."},{"Attribute Name":">>Include","Tag":"Baseline ."},{"Attribute Name":">Contrast/Bolus Ingredient Code Sequence","Tag":"(0018,9338)","Type":"2","Attribute Description":"Active ingredient of agent. Zero or more Items shall be included in this Sequence."},{"Attribute Name":">>Include","Tag":"Baseline ."},{"Attribute Name":">Contrast/Bolus Volume","Tag":"(0018,1041)","Type":"2","Attribute Description":"Total volume administered in milliliters of diluted contrast agent."},{"Attribute Name":">Contrast/Bolus Ingredient Concentration","Tag":"(0018,1049)","Type":"2","Attribute Description":"Milligrams of active ingredient per milliliter of agent."},{"Attribute Name":">Contrast/Bolus Ingredient Percent by Volume","Tag":"(0052,0001)","Type":"3","Attribute Description":"Percentage by volume of active ingredient in the total volume."},{"Attribute Name":">Contrast/Bolus Ingredient Opaque","Tag":"(0018,9425)","Type":"3","Attribute Description":"Absorption of the ingredient greater than the absorption of water (tissue).  Enumerated Values:  YES      NO      See ."},{"Attribute Name":">Contrast/Bolus T1 Relaxivity","Tag":"(0018,0013)","Type":"3","Attribute Description":"T1 Relaxivity of the MR Contrast/Bolus used specified in s-1*mmol-1 specified at body temperature in human blood plasma."},{"Attribute Name":">Contrast Administration Profile Sequence","Tag":"(0018,9340)","Type":"3","Attribute Description":"Sequence that describes one or more phases of contrast administered. One or more Items are permitted in this Sequence."},{"Attribute Name":">>Contrast/Bolus Volume","Tag":"(0018,1041)","Type":"2","Attribute Description":"Volume administered during this phase in milliliters of diluted contrast agent."},{"Attribute Name":">>Contrast/Bolus Start Time","Tag":"(0018,1042)","Type":"3","Attribute Description":"Time of start of administration."},{"Attribute Name":">>Contrast/Bolus Stop Time","Tag":"(0018,1043)","Type":"3","Attribute Description":"Time of end of administration."},{"Attribute Name":">>Contrast Flow Rate","Tag":"(0018,1046)","Type":"3","Attribute Description":"Rate of administration in milliliters/sec. Only a single value shall be present."},{"Attribute Name":">>Contrast Flow Duration","Tag":"(0018,1047)","Type":"3","Attribute Description":"Duration of injection in seconds. Only a single value shall be present."}];